AS Roma transfer for Jayden Oosterwolde collapses after medical tests reveal serious injury

A transfer that looked like a done deal turned into a cautionary tale about the gap between a handshake and a signature. Jayden Oosterwolde’s move from Fenerbahçe to AS Roma collapsed after medical examinations in Rome revealed an injury significantly more severe than either club had anticipated.

Oosterwolde, the 25-year-old Dutch defender, arrived in the Italian capital on August 25 for what was supposed to be routine medical clearance. Instead, the tests flagged a muscle and tendon issue that could require surgery and sideline him for up to three months, effectively torpedoing a deal that had been structured as a paid loan with a path to a permanent signing.

What went wrong in Rome

The injury traces back to August 5, when Oosterwolde picked up what was initially diagnosed as a hamstring problem during Fenerbahçe’s UEFA Champions League qualifier against Sturm Graz. Roma’s medical staff conducted deeper examinations that revealed a tendon component to the injury, a finding that significantly escalated the risk profile.

The original deal was structured as a paid loan of roughly €1-1.5 million, with an option to buy set between €15-18 million. That purchase option would have become obligatory after Oosterwolde made 15-20 appearances for Roma. In other words, the club was set to commit up to €18 million for a player who might not be available for competitive action until November at the earliest.

By August 27, Roma was reportedly weighing two options: restructure the agreement as a free loan with more stringent conditions on the buy clause, or walk away entirely. The club ultimately chose the latter, and Oosterwolde returned to Istanbul.

The due diligence lesson at the end of every transfer window

Oosterwolde is 25, born April 26, 2001, and has been a reliable presence in Fenerbahçe’s squad, accumulating 112 appearances while contributing 3 goals and 1 assist. The injury occurred just 20 days before he showed up for his medical. Initial assessments at Fenerbahçe classified it as a hamstring issue. Roma’s medical team, conducting their own independent evaluation, reached a materially different conclusion.

A €1.5 million loan fee is easy to absorb. A mandatory €18 million purchase triggered by appearances, when the player might miss a quarter of the season recovering from surgery, changes the math considerably.

What this means for both clubs

Roma’s decision to walk away rather than accept a restructured deal suggests the medical findings were genuinely alarming. Clubs routinely negotiate around injury concerns, adjusting fees or adding performance-based clauses to account for risk. When a club decides the risk isn’t worth managing at any price, that tells you something about the severity of what the doctors found.

For Fenerbahçe, they retain a player who, when healthy, has been a consistent performer across 112 matches. The more immediate concern is managing his recovery and ensuring the tendon issue is properly treated, whether that means surgery or conservative rehabilitation.

Disclosure: This article was edited by Editorial Team. For more information on how we create and review content, see our Editorial Policy.